Qvigstad E - Search Results

1

Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy.

Jacobsen AF, Qvigstad E, Sandset PM. Jacobsen AF, et al. Among authors: qvigstad e. BJOG. 2003 Feb;110(2):139-44. BJOG. 2003. PMID: 12618157

2

[Treatment of venous thromboembolism in pregnancy with low molecular weight heparin].

Jacobsen AF, Qvigstad E, Sandset PM. Jacobsen AF, et al. Among authors: qvigstad e. Tidsskr Nor Laegeforen. 2000 Aug 30;120(20):2448-9. Tidsskr Nor Laegeforen. 2000. PMID: 11475236 Free article. Norwegian. No abstract available.

3

Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.

Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM. Eilertsen AL, et al. Among authors: qvigstad e. BJOG. 2008 May;115(6):773-9. doi: 10.1111/j.1471-0528.2008.01690.x. Epub 2008 Mar 19. BJOG. 2008. PMID: 18355366 Clinical Trial.

4

Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).

Høibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrøm E, Sandset PM. Høibraaten E, et al. Among authors: qvigstad e. Thromb Haemost. 2000 Dec;84(6):961-7. Thromb Haemost. 2000. PMID: 11154141 Clinical Trial.

5

The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.

Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM. Høibraaten E, et al. Among authors: qvigstad e. Thromb Haemost. 2001 May;85(5):775-81. Thromb Haemost. 2001. PMID: 11372667 Clinical Trial.

6

Deep vein thrombosis after elective cesarean section.

Jacobsen AF, Drolsum A, Klow NE, Dahl GF, Qvigstad E, Sandset PM. Jacobsen AF, et al. Among authors: qvigstad e. Thromb Res. 2004;113(5):283-8. doi: 10.1016/j.thromres.2004.03.008. Thromb Res. 2004. PMID: 15183039

7

Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.

Eilertsen AL, Sandvik L, Mowinckel MC, Andersen TO, Qvigstad E, Sandset PM. Eilertsen AL, et al. Among authors: qvigstad e. Thromb Res. 2007;120(3):371-9. doi: 10.1016/j.thromres.2006.10.013. Epub 2006 Dec 15. Thromb Res. 2007. PMID: 17156824 Clinical Trial.

8

Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation.

Eilertsen AL, Qvigstad E, Andersen TO, Sandvik L, Sandset PM. Eilertsen AL, et al. Among authors: qvigstad e. Maturitas. 2006 Oct 20;55(3):278-87. doi: 10.1016/j.maturitas.2006.04.012. Epub 2006 May 18. Maturitas. 2006. PMID: 16713143 Clinical Trial.

9

Long-term outcomes following laparoscopic supracervical hysterectomy.

Lieng M, Qvigstad E, Istre O, Langebrekke A, Ballard K. Lieng M, et al. Among authors: qvigstad e. BJOG. 2008 Dec;115(13):1605-10. doi: 10.1111/j.1471-0528.2008.01854.x. Epub 2008 Aug 25. BJOG. 2008. PMID: 18752588

10

Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial.

Oppegaard KS, Qvigstad E, Nesheim BI. Oppegaard KS, et al. Among authors: qvigstad e. BJOG. 2006 Jan;113(1):58-64. doi: 10.1111/j.1471-0528.2005.00798.x. BJOG. 2006. PMID: 16398773 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters